AVITA Medical at-the-market offering
The stock is listed on the Nasdaq Global Market
Davis Polk advised the sales agent in connection with the establishment of an SEC-registered at-the-market program by AVITA Medical, Inc. of up to 3,799,164 shares of their common stock. The common stock is listed on the Nasdaq Global Market under the symbol “RCEL.”
Based in Valencia, California, AVITA Medical is a regenerative medicine company focused on the research, development, and commercialization of its technology platform in treating burns, chronic wounds, scar revision and vitiligo. AVITA Medical’s proprietary collection and FDA-approved application technology provides innovative treatment solutions derived from the regenerative properties of a patient’s own skin.
The Davis Polk corporate team included partner Alan F. Denenberg and associates Elsie Cheang and Ivey Eugene. Partner David R. Bauer and associates Adrian Rabin and Emma C. Himes provided intellectual property advice. Partner Mario J. Verdolini and associates Eitan Ulmer and Ted Lee provided tax advice. Members of the Davis Polk team are based in the Northern California and New York offices.